J0610 — Injection, calcium gluconate (fresenius kabi), per 10 ml
J0610 is a HCPCS Level II code for injection, calcium gluconate (fresenius kabi), per 10 ml. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on March 31, 2023 and is not valid on new claims.
This code has been terminated
CMS terminated J0610 on March 31, 2023. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0610
- Long descriptor
- Injection, calcium gluconate (fresenius kabi), per 10 ml
- Short descriptor
- Calcium glucon (fresenius)
- Added
- January 1, 1982
- Terminated
- March 31, 2023
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0610
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0610 is not quite right, the correct code is very often within a few positions of it.
- J0602Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
- J0603Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0604Cinacalcet, oral, 1 mg, (for esrd on dialysis)
- J0605Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
- J0606Injection, etelcalcetide, 0.1 mg
- J0607Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
- J0608Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
- J0609Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
- J0611Injection, calcium gluconate (wg critical care), per 10 mlterminated
- J0612Injection, calcium gluconate, not otherwise specified, 10 mg
- J0613Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
- J0614Injection, treosulfan, 50 mg
- J0615Calcium acetate, oral, 23 mg (for esrd on dialysis)
- J0616Injection, metoprolol tartrate, 1 mg
- J0618Injection, calcium chloride, 2 mg
- J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml
Questions about J0610
What is HCPCS code J0610?
J0610 is a HCPCS Level II code for injection, calcium gluconate (fresenius kabi), per 10 ml. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0610?
The CMS HCPCS file marks J0610 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J0610 still valid?
No. J0610 was terminated on March 31, 2023 and should not be used on new claims.